ArticleACS omega2024

Development and Optimization of Proniosomal Formulation of Irbesartan Using a Box-Behnken Design to Enhance Oral Bioavailability: Physicochemical Characterization and

Md Ali Mujtaba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.